Results 61 to 70 of about 12,026,666 (219)

Factors Influencing Functional Heterogeneity in Human Mucosa-Associated Invariant T Cells

open access: yesFrontiers in Immunology, 2018
Mucosa-associated invariant T (MAIT) cells are unconventional innate-like T cells that recognize microbial riboflavin metabolites presented by the monomorphic MHC class I-related (MR1) molecule.
Joana Dias   +12 more
doaj   +1 more source

CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression. [PDF]

open access: yesPLoS ONE, 2014
Mucosal-associated invariant T (MAIT) cells are characterized by the combined expression of the semi-invariant T cell receptor (TCR) Vα7.2, the lectin receptor CD161, as well as IL-18R, and play an important role in antibacterial host defense of the gut.
Johanna Maria Eberhard   +9 more
doaj   +1 more source

Varicella Zoster Virus infects mucosal associated Invariant T cells

open access: yesFrontiers in Immunology, 2023
IntroductionMucosal Associated Invariant T (MAIT) cells are innate-like T cells that respond to conserved pathogen-derived vitamin B metabolites presented by the MHC class I related-1 molecule (MR1) antigen presentation pathway.
Shivam K. Purohit   +3 more
doaj   +1 more source

Use of a MAIT Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination

open access: yesPathogens and Immunity, 2022
Background: Mucosal-associated invariant T (MAIT) cells are innate-like T cells enriched in the mucosa with capacity for B-cell help. We hypothesize that targeting MAIT cells, using a MAIT-activating ligand as an adjuvant, could improve mucosal vaccine ...
Owen Jensen   +6 more
doaj   +1 more source

Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation

open access: yesFrontiers in Immunology, 2017
Mucosal-associated invariant T (MAIT) cells are innate-like T cells which are important in the defense against certain bacteria and yeast. The reconstitution of MAIT cells after allogeneic hematopoietic stem cell transplantation (HSCT) is not known.
Martin Solders   +8 more
doaj   +1 more source

Stepwise development of MAIT cells in mouse and human. [PDF]

open access: yesPLoS Biology, 2009
Mucosal-associated invariant T (MAIT) cells display two evolutionarily conserved features: an invariant T cell receptor (TCR)alpha (iTCRalpha) chain and restriction by the nonpolymorphic class Ib major histocompatibility complex (MHC) molecule, MHC ...
Emmanuel Martin   +14 more
doaj   +1 more source

High CD26 and Low CD94 Expression Identifies an IL-23 Responsive Vδ2+ T Cell Subset with a MAIT Cell-like Transcriptional Profile [PDF]

open access: yes, 2020
Vδ2+ T cells play a critical role in immunity to micro-organisms and cancer but exhibit substantial heterogeneity in humans. Here, we demonstrate that CD26 and CD94 define transcriptionally, phenotypically, and functionally distinct Vδ2+ T cell subsets ...
Nguyen-Robertson, Catriona V.   +32 more
core   +1 more source

MAIT cells in metabolic diseases

open access: yesMolecular Metabolism, 2019
Metabolic diseases represent a wide category of alterations affecting metabolism. These pathologies are notably marked by inflammation that implicates the immune system. Mucosal Associated Invariant (MAI)T cells are immune cells expressing a semi-invariant TCR able to recognize bacterial and fungal vitamin B metabolites.
Bertrand, Léo, Lehuen, Agnès
openaire   +4 more sources

Molecular Analyses Define Vα7.2-Jα33+ MAIT Cell Depletion in HIV Infection: A Case-Control Study [PDF]

open access: yes, 2015
Mucosal-associated invariant T (MAIT) cells are an abundant antibacterial innate-like lymphocyte population. There are conflicting reports as to their fate in HIV infection.
Cosgrove, Cormac   +19 more
core   +1 more source

Biofabrication of 3D Breast cancer models for dissecting the cytotoxic response of human T cells expressing engineered MAIT cell receptors

open access: yesBiofabrication, 2022
Immunotherapy has revolutionized cancer treatment with the advent of advanced cell engineering techniques aimed at targeted therapy with reduced systemic toxicity.
Madhuri Dey   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy